Tissue Regenix Share Discussion Threads

[thompsonminor] 19/8/2020 16:10

Watching from the sidelines, this share price should be doing so much better. That said, it's impressive to see the company in the same comparison cohort as Smith & Nephew, Medtronic, Wright Medical Group and Integra LifeSciences in the latest Fortune Business Insights, which predicts 26% CAGR in Regenerative Medicine Market (2019 to 2026)

[carlisle44] 18/8/2020 15:21

I would prefer spike followed by spike

[hodhasharon] 18/8/2020 11:18

Me too. I can't believe the accumulation was completed under the Radar. How many holdings emails does the average retail investor need?

[geoff0458] 18/8/2020 11:11

I would prefer nice and steady, rather than spikes retraces.

[hodhasharon] 18/8/2020 11:01

A few more ticks up and the rampers will be along no doubt.

[sweendog21] 17/8/2020 11:10

Booom she's starting to move

[hodhasharon] 17/8/2020 10:16

Lot of volume today. Hopefully the rampers don't move in on this.

[channel pirate] 17/8/2020 07:06

17/08/2020 7:00am

UK Regulatory (RNS & others)



RNS Number : 2534W

Tissue Regenix Group PLC

17 August 2020

Tissue Regenix Group plc

Relocation of UK head office and manufacturing facility

Leeds, UK, 17 August 2020 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or the "Group"), the regenerative medical devices company, announces the relocation of the Company's UK head office and manufacturing facilities to Garforth, Leeds, in November 2020.

The strategic decision to relocate the Company's UK operations from nearby Swillington, Leeds, was made as part of the ongoing overhead cost saving initiatives being implemented by Tissue Regenix and is expected to reduce the Group's overhead spend by over GBP400,000 on an annualised basis from 2021.

As part of the relocation programme, the Group will outsource elements of the production cycle relating to testing and packaging, but will retain its processing capabilities including the manufacturing of OrthoPure(R) XT.

Gareth Jones, Interim Chief Executive Officer of Tissue Regenix, commented:

"We remain committed to reducing our overhead cost base to drive us towards a position of break-even. Following a review of our near-term activity, this relocation will allow us to reduce our manufacturing footprint and associated costs, whilst importantly protecting the supply of our products. We also remain within the Leeds and York area to continue to support our local community and retain our valuable employee base. I am pleased we have successfully identified an action plan that addresses these criteria."

[hodhasharon] 15/8/2020 18:51

I’d be amazed if TRX are not trading at 10p+ by the end of 2020.

Check out the holdings notifications > accumulation.

[livewireplus] 15/8/2020 18:04

Well it is still only about 0.64% of total shares - let us see what the future brings - hopefullt no hat eating ...

[pennstreet] 15/8/2020 17:59

What's the 44m trade all about?

[laptop15] 14/8/2020 15:32

https://twitter.com/laptop1515/status/1294278799505395713

[laptop15] 14/8/2020 15:09

https://twitter.com/laptop1515/status/1294274009060773891

[laptop15] 14/8/2020 13:00

What's your avg? It does look cheap

[hodhasharon] 14/8/2020 12:22

No idea, just look at the chart, that's all you need.

The chart says initial '10-bagger' to me.

I'm fully loaded and just waiting for the rampers to arrive.

[laptop15] 14/8/2020 12:08

What news flow is due guys??

[hodhasharon] 13/8/2020 20:22

We traded quite happily at 60 Xs today’s price a couple or three years ago. This has short term 30 bagger written all over it.

[encarter] 13/8/2020 19:15

One of those potential 10 baggers so definitely worth a punt imho.

[b1inkers] 13/8/2020 16:44

It comes down to how future demand plays out, which won't be known until at least the middle of next year.

My limited understanding is that the medical devices their products will replace (e.g. metal/plastic dental implants or heart valves) can corrode over time influencing chronic inflammatory illnesses and/or hypersensitivity. Even the FDA are mildly concerned: hxxps://melisa.org/bsem-melisa-conference-2018/?v=79cba1185463

Now, in a well functioning healthcare market where patient outcomes were the first priority this would, in time, translate to strong demand for TRX' portfolio. So I suppose that's what we're betting upon.

[hodhasharon] 13/8/2020 16:00

"Investment summary: TRX has a portfolio of innovative regenerative products
with regulatory approval in both the US and EU. Realignment of the commercial
strategy to maximise sales potential through strategic and distribution partnerships
has been successful, resulting in increased demand for products. Having
secured the required funding to invest in scaling the manufacturing facilities, the
market will start to take note when management delivers on future milestones."

[tvh123] 13/8/2020 15:54

Summary of the current state of play on pg 37

[hodhasharon] 12/8/2020 16:10

sssshhhhh keep this one under the Radar just a little bit longer. Will double up tomorrow following WSG results.

[pennstreet] 05/8/2020 11:21

10-12p over the next couple of months? That's a bit optimistic, lol

[hodhasharon] 05/8/2020 10:21

Yeah it's ready for liftoff. I'm fully loaded as of yesterday AM. Just want a nice steady rise to the 1-2p region over the next couple of months rather than it be ramped to 2p this week before a sharp return to sub-1p next week.